Pharmaceuticals

Genomic Cancer Panel And Profiling Market to Reach $14.27 Billion by 2029, Growing at a CAGR of 8.5%

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Genomic Cancer Panel And Profiling Industry Expected To Reach By 2029, Starting From 2025 Levels?

The genomic cancer panel and profiling market size has demonstrated significant expansion in recent years. Its valuation is projected to increase from $9.47 billion in 2024 to $10.28 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.6%. Historically, this growth can be attributed to an escalating global cancer burden, increased utilization in clinical trials, the expansion of diagnostic infrastructure, heightened awareness regarding genetic testing, and growing financial support from governments and research institutions.

The genomic cancer panel and profiling market size is anticipated to experience robust growth over the next few years, projected to reach $14.27 billion by 2029, driven by a compound annual growth rate (CAGR) of 8.5%. This expansion during the forecast period can be attributed to factors such as the increasing applications of liquid biopsy, its growing role in early detection, the rise of tailored therapies, and a greater number of companion diagnostics approvals. Prominent trends expected in this period include the integration of AI and machine learning into genomic data interpretation, the development of multi-omics approaches, cloud-based genomic data storage and analysis solutions, integration with electronic health records, and the wider deployment of next-generation sequencing (NGS) platforms.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24225&type=smp

Which Industry Drivers Are Expected To Accelerate The Genomic Cancer Panel And Profiling Market From 2025 To 2029?

The anticipated increase in cancer cases is set to propel the growth of the genomic cancer panel and profiling market. Cancer is defined as a disease marked by the uncontrolled proliferation and dissemination of abnormal cells throughout the body. The rising incidence of cancer can be linked to factors such as an aging population, which increases the likelihood of developing the disease as individuals live longer. Genomic cancer panels and profiling are utilized in oncology to pinpoint genetic mutations and biomarkers, thereby enabling tailored treatment strategies and enhancing the early detection and surveillance of the illness. For instance, in January 2024, the American Cancer Society, a U.S.-based nonprofit organization, reported that in 2022, approximately 20 million new cancer cases were recorded globally, resulting in 9.7 million deaths; primarily driven by population growth, the worldwide cancer burden is projected to reach 35 million cases by 2050. Consequently, the increasing prevalence of cancer will drive the expansion of the genomic cancer panel and profiling market.

What Are The Major Segment Categories Driving The Genomic Cancer Panel And Profiling Market Growth?

The genomic cancer panel and profiling market covered in this report is segmented –

1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies

3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel

4) By Application: Clinical, Research

5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues

2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids

What Trends Are Expected To Drive The Genomic Cancer Panel And Profiling Market?

Leading companies operating in the genomic cancer panel and profiling market are increasingly focusing on technological advancements, such as next-generation sequencers, to enhance the accuracy, speed, and comprehensiveness of cancer diagnostics and facilitate more personalized treatment decisions. These next-generation sequencers are sophisticated DNA sequencing technologies that enable rapid, high-throughput analysis of genetic material to identify mutations, variations, and other genomic features. As an illustration, in April 2025, QIAGEN N.V., a biotechnology company located in the Netherlands, introduced QIAseq panels tailored for next-generation sequencers, which allow for comprehensive genomic profiling by analyzing more than 700 genes. These panels are designed for both research and clinical applications, with the objective of improving cancer diagnostics and treatment strategies.

Which Leading Players Are Enhancing Their Genomic Cancer Panel And Profiling Market Presence Worldwide?

Major companies operating in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/genomic-cancer-panel-and-profiling-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Genomic Cancer Panel And Profiling Market?

North America was the largest region in the genomic cancer panel and profiling market in 2024. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Genomic Cancer Panel And Profiling Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24225&type=smp

Browse Through More Reports Similar to the Global Genomic Cancer Panel And Profiling Market 2025, By The Business Research Company

Genomics In Cancer Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Urothelial Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/urothelial-cancer-drugs-global-market-report

Ovarian Cancer Drugs Market 2025

https://www.thebusinessresearchcompany.com/report/ovarian-cancer-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795